Baricitinib in paediatric rheumatology: real-world safety experience from a UK tertiary centre

Authors
Category Primary study
Conference32nd European Paediatric Rheumatology Congress
Year 2025
This article has no abstract
Epistemonikos ID: 60e54636a1034aa5f6d1dd82845006217e451b18
First added on: Nov 18, 2025